Literature DB >> 23224654

Can a phone call be more effective than an intrathecal implanted pump?

Sebastiano Mercadante, Patrizia Giardina.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23224654     DOI： 10.1007/s00520-012-1665-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  15 in total

1.  Re: Rauck et al. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain. 2003 Oct;4(8):441-7.

Authors:  Sebastiano Mercadante
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

2.  Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases.

Authors:  Sriram Yennurajalingam; Rony Dev; Paul W Walker; Suresh K Reddy; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

3.  Spinal analgesia: where is the evidence?

Authors:  Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2010-06-12       Impact factor: 3.603

4.  Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Patrizia Villari; Edoardo Arcuri
Journal:  Anesth Analg       Date:  2005-05       Impact factor: 5.108

Review 5.  Spinal analgesia for advanced cancer patients: an update.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Vittorio Gebbia
Journal:  Crit Rev Oncol Hematol       Date:  2011-06-17       Impact factor: 6.312

Review 6.  Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

Authors:  Jianren Mao; Donald D Price; David J Mayer
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

7.  The inappropriate use of the epidural route in cancer pain.

Authors:  S Mercadante; A Agnello; M G Armata; S Pumo
Journal:  J Pain Symptom Manage       Date:  1997-04       Impact factor: 3.612

8.  A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.

Authors:  Akhila Reddy; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-05-30       Impact factor: 3.612

9.  Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Villari; Patrizia Ferrera; Salvatore Riina; Fabrizio David; Salvatore Mangione
Journal:  Clin J Pain       Date:  2007 Nov-Dec       Impact factor: 3.442

10.  Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain.

Authors:  Richard L Rauck; David Cherry; Michael F Boyer; Peter Kosek; Joseph Dunn; Kenneth Alo
Journal:  J Pain       Date:  2003-10       Impact factor: 5.820
View more
  1 in total

Review 1.  Pharmacological options for the management of refractory cancer pain-what is the evidence?

Authors:  B Afsharimani; K Kindl; P Good; J Hardy
Journal:  Support Care Cancer       Date:  2015-03-07       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.